Clinical trial
6-Month Safety And Efficacy Study Of TTP488 In Patients With Type 2 Diabetes And…
NCT00287183 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00287183 |
|---|---|
| Title | 6-Month Safety And Efficacy Study Of TTP488 In Patients With Type 2 Diabetes And Persistent Albuminuria |
| Official title | Double-Blind, Randomized, Placebo-Controlled, Phase IIa, Multicenter Study In Patients With Type 2 Diabetes And Persistent Albuminuria To Evaluate The Safety And Efficacy Of A Six Month Regimen Of Orally-Administered TTP488 |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetic Nephropathy |
| Intervention type | Drug, Other |
| Interventions | PF-04494700 (TTP488), Placebo |
| Enrollment | 110 |
| Start date | Feb 1, 2006 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Feb 6, 2006 |
| Last update posted | Oct 1, 2009 |
| Countries | Canada |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: